Antonia Patsialou

Title: Antonia Patsialou: Innovator in Cancer Prognosis

Introduction

Antonia Patsialou is a prominent inventor based in Pelham, NY (US). She has made significant contributions to the field of cancer research, particularly in the area of tumor metastasis and recurrence. Her innovative work has the potential to improve patient outcomes and advance cancer treatment methodologies.

Latest Patents

Antonia holds 1 patent titled "Human invasion signature for prognosis of metastatic risk." This patent provides methods and products for determining if a subject with a tumor is at risk of metastasis or recurrence after treatment. The techniques outlined in her patent aim to enhance the understanding of cancer progression and offer new avenues for treatment.

Career Highlights

Antonia is affiliated with the Albert Einstein College of Medicine, where she conducts her research. Her work focuses on developing methods to assess metastatic risk, which is crucial for tailoring cancer treatment plans. Through her research, she has contributed to the scientific community's understanding of tumor behavior and patient prognosis.

Collaborations

Antonia collaborates with esteemed colleagues, including John S Condeelis, to further her research initiatives. These partnerships enhance the depth and breadth of her work, allowing for a multidisciplinary approach to cancer research.

Conclusion

Antonia Patsialou is a dedicated inventor whose work in cancer prognosis is paving the way for advancements in treatment strategies. Her innovative patent and collaboration with leading researchers highlight her commitment to improving patient care in oncology.